These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31973599)

  • 1. Cluster-Randomized Trial of Thrombolysis Implementation Support in Metropolitan and Regional Australian Stroke Centers: Lessons for Individual and Systems Behavior Change.
    Levi CR; Attia JA; D'Este C; Ryan AE; Henskens F; Kerr E; Parsons MW; Sanson-Fisher RW; Bladin CF; Lindley RI; Middleton S; Paul CL; ;
    J Am Heart Assoc; 2020 Feb; 9(3):e012732. PubMed ID: 31973599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
    Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses of the Turkish National Intravenous Thrombolysis Registry.
    Kutluk K; Kaya D; Afsar N; Arsava EM; Ozturk V; Uzuner N; Giray S; Topcuoglu MA; Gungor L; Sirin H; Yaka E; Ozdemir O; Dalkara T;
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1041-1047. PubMed ID: 26853139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of Intravenous Tissue Plasminogen Activator and Reasons for Nonuse in Acute Ischemic Stroke in Saudi Arabia.
    Al Khathaami AM; Al Bdah B; Tarawneh M; Alskaini M; Alotaibi F; Alshalan A; Almuhraj M; Aldaham D; Alotaibi N
    J Stroke Cerebrovasc Dis; 2020 May; 29(5):104761. PubMed ID: 32173225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis ImPlementation in Stroke (TIPS): evaluating the effectiveness of a strategy to increase the adoption of best evidence practice--protocol for a cluster randomised controlled trial in acute stroke care.
    Paul CL; Levi CR; D'Este CA; Parsons MW; Bladin CF; Lindley RI; Attia JR; Henskens F; Lalor E; Longworth M; Middleton S; Ryan A; Kerr E; Sanson-Fisher RW;
    Implement Sci; 2014 Mar; 9():38. PubMed ID: 24666591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis implementation intervention and clinical outcome: a secondary analysis of a cluster randomized trial.
    Hasnain MG; Paul CL; Attia JR; Ryan A; Kerr E; Oldmeadow C; D'Este CA; Bivard A; Hubbard IJ; Milton AH; Levi CR
    BMC Cardiovasc Disord; 2020 Oct; 20(1):432. PubMed ID: 33023494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional Learning Collaboratives Produce Rapid and Sustainable Improvements in Stroke Thrombolysis Times.
    Prabhakaran S; Lee J; O'Neill K
    Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):585-92. PubMed ID: 27625405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and effectiveness of intravenous thrombolysis with recombinant tissue plasminogen activator in eighty years and older acute ischemic stroke patients.
    Chen Y; Li CH; Wang YX; Zhang CH; Dong Z; Zhang FF; Wang JH; Zhang PL
    Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1852-8. PubMed ID: 26044231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
    Fan Y; Liao X; Pan Y; Dong K; Wang Y; Wang Y;
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
    ; Sandercock P; Wardlaw JM; Lindley RI; Dennis M; Cohen G; Murray G; Innes K; Venables G; Czlonkowska A; Kobayashi A; Ricci S; Murray V; Berge E; Slot KB; Hankey GJ; Correia M; Peeters A; Matz K; Lyrer P; Gubitz G; Phillips SJ; Arauz A
    Lancet; 2012 Jun; 379(9834):2352-63. PubMed ID: 22632908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated Intravenous Thrombolysis for Early Recurrent Stroke: Challenging the Exclusion Criterion.
    Kahles T; Mono ML; Heldner MR; Baumgartner RW; Sarikaya H; Luft A; Bohlhalter S; Traenka C; Engelter ST; Kurka N; Köhrmann M; Curtze S; Michel P; Tatlisumak T; Nedeltchev K
    Stroke; 2016 Aug; 47(8):2133-5. PubMed ID: 27364530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
    Sørensen SB; Barazangi N; Chen C; Wong C; Grosvenor D; Rose J; Bedenk A; Morrow M; McDermott D; Hove JD; Tong DC
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous thrombolysis in stroke mimics: results from the SITS International Stroke Thrombolysis Register.
    Keselman B; Cooray C; Vanhooren G; Bassi P; Consoli D; Nichelli P; Peeters A; Sanak D; Zini A; Wahlgren N; Ahmed N; Mazya MV
    Eur J Neurol; 2019 Aug; 26(8):1091-1097. PubMed ID: 30793434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Door-to-needle time for thrombolysis: a secondary analysis of the TIPS cluster randomised controlled trial.
    Hasnain MG; Paul CL; Attia JR; Ryan A; Kerr E; D'Este C; Hall A; Milton AH; Hubbard IJ; Levi CR
    BMJ Open; 2019 Dec; 9(12):e032482. PubMed ID: 31843839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
    Pretnar Oblak J; Sabovic M; Frol S
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous Tissue Plasminogen Activator in Stroke Mimics.
    Ali-Ahmed F; Federspiel JJ; Liang L; Xu H; Sevilis T; Hernandez AF; Kosinski AS; Prvu Bettger J; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC; Peterson ED; Xian Y
    Circ Cardiovasc Qual Outcomes; 2019 Aug; 12(8):e005609. PubMed ID: 31412730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Risk of Hemorrhagic Transformation After Thrombolysis for Acute Ischemic Stroke in Chinese Versus North Americans: A Comparative Study.
    Xu X; Wang D; Wang F; Norton C; Liu X; Selim M
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2381-2387. PubMed ID: 29778315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular Treatment With or Without Prior Intravenous Alteplase for Acute Ischemic Stroke.
    Chalos V; LeCouffe NE; Uyttenboogaart M; Lingsma HF; Mulder MJHL; Venema E; Treurniet KM; Eshghi O; van der Worp HB; van der Lugt A; Roos YBWEM; Majoie CBLM; Dippel DWJ; Roozenbeek B; Coutinho JM;
    J Am Heart Assoc; 2019 Jun; 8(11):e011592. PubMed ID: 31140355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.